Science Press Releases
SEE OTHER BRANDS

Informing on science news in the world

Science Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science Press Releases.

Press releases published on April 17, 2025

Injectable Drug Delivery Devices Market Set to Reach $317.2 Billion by 2029

Injectable Drug Delivery Devices Market Set to Reach $317.2 Billion by 2029

Boston, April 17, 2025 (GLOBE NEWSWIRE) -- BCC Research reveals in its new report, Global Injectable Drug Delivery Devices Market, the market for injectable drug delivery devices is projected to grow to $317.2 billion by 2029 at a five-year compound annual …

uniQure Announces FDA Breakthrough Therapy Designation Granted to AMT-130 for the Treatment of Huntington’s Disease

uniQure Announces FDA Breakthrough Therapy Designation Granted to AMT-130 for the Treatment of Huntington’s Disease

~ Breakthrough Therapy designation based on clinical evidence from Phase I/II trials showing meaningful slowing of disease progression ~ ~ Additional regulatory update and guidance on the Biologics License Application submission expected in the second …

EYLEA HD® (aflibercept) Injection 8 mg sBLA Accepted for FDA Priority Review for Both the Treatment of Macular Edema Following Retinal Vein Occlusion (RVO) and for Monthly Dosing in Approved Indications

EYLEA HD® (aflibercept) Injection 8 mg sBLA Accepted for FDA Priority Review for Both the Treatment of Macular Edema Following Retinal Vein Occlusion (RVO) and for Monthly Dosing in Approved Indications

If approved, EYLEA HD would be the first and only treatment for RVO indicated for up to every 8-week dosing after an initial monthly dosing period – halving the number of injections that are indicated for all other anti-VEGF therapies Potential for as …

Agios to Webcast Conference Call of First Quarter Financial Results on May 1, 2025

Agios to Webcast Conference Call of First Quarter Financial Results on May 1, 2025

CAMBRIDGE, Mass., April 17, 2025 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and pyruvate kinase (PK) activation pioneering therapies for rare diseases, today announced the company will host a conference …

Atana Recognized for Innovation and Technology in Ragan’s 2025 Employee Communications Awards

Atana Recognized for Innovation and Technology in Ragan’s 2025 Employee Communications Awards

BELLEVUE, Wash., April 17, 2025 (GLOBE NEWSWIRE) -- Seeking to redefine workplace culture and training, Atana is proud to announce that it has been named a winner in Ragan’s Employee Communications Awards. The Innovation and Technology Award for HR Tool/ …

Tilray Brands Announces Proposed Reverse Stock Split and Corresponding Special Meeting of Stockholders

Tilray Brands Announces Proposed Reverse Stock Split and Corresponding Special Meeting of Stockholders

NEW YORK and LEAMINGTON, Ontario, April 17, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray” or “Company”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of beverage, cannabis and wellness …

Atea Pharmaceuticals Appoints Howard H. Berman to Board of Directors and Announces Share Repurchase Program

Atea Pharmaceuticals Appoints Howard H. Berman to Board of Directors and Announces Share Repurchase Program

BOSTON, April 17, 2025 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (“Atea” or “Company”), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral diseases, today …

AAFA Announces Innovative Program in Texas Serving Communities Facing Highest Rates of Asthma

AAFA Announces Innovative Program in Texas Serving Communities Facing Highest Rates of Asthma

Washington, DC, April 17, 2025 (GLOBE NEWSWIRE) -- The Asthma and Allergy Foundation of America (AAFA) announces an innovative new collaboration with Health Care Originals, Inc. (HCO) and Rabbit Air as part of AAFA’s Health Equity Advancement and …

Nurix Announces FDA Clearance of IND Application for GS-6791/NX-0479 - a Novel IRAK4 Degrader for Inflammatory Conditions

Nurix Announces FDA Clearance of IND Application for GS-6791/NX-0479 - a Novel IRAK4 Degrader for Inflammatory Conditions

Collaboration partner, Gilead Sciences, to begin Phase 1 single ascending dose (SAD) and multiple ascending dose (MAD) study in healthy volunteers in Q2 2025 GS-6791/NX-0479 has potential clinical applications across multiple blockbuster markets in …

Cryptocurrency trends and policies are connected, SIX MINING stands at the "new outlet"

Cryptocurrency trends and policies are connected, SIX MINING stands at the "new outlet"

London, UK, April 17, 2025 (GLOBE NEWSWIRE) -- If El Salvador is integrating the country into the Bitcoin ecosystem through policy means, then SIX MINING represents the civil power of cryptocurrency technology application. The platform not only deploys …

Smart Water Bottle Market to Reach $360.7 Million by 2027 in short term and $896.6 million by 2035 Globally, at 11.2% CAGR: Allied Market Research

Smart Water Bottle Market to Reach $360.7 Million by 2027 in short term and $896.6 million by 2035 Globally, at 11.2% CAGR: Allied Market Research

Wilmington, Delaware, April 17, 2025 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, "Smart Water Bottle Market by Technology (Hydration Tracking Sensors, Temperature Control, UV-C Sterilization, and Bluetooth/Wi-Fi Connectivity), …

Airport Ground Handling Market to Reach $83.8 Billion, Globally, by 2033 at 10.1% CAGR: Allied Market Research

Airport Ground Handling Market to Reach $83.8 Billion, Globally, by 2033 at 10.1% CAGR: Allied Market Research

Wilmington, Delaware, April 17, 2025 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, "Airport Ground Handling Market by Service (Passenger Handling, Ramp Handling, Cargo Handling, and Others), Airport (Domestic, and International), …

Ostarine (MK 2866) PCT: Ostarine Before & After Result Benefits - Legal Ostarine MK-2866 SARM For Sale From CrazyBulk

Ostarine (MK 2866) PCT: Ostarine Before & After Result Benefits - Legal Ostarine MK-2866 SARM For Sale From CrazyBulk

Albany, New York, April 17, 2025 (GLOBE NEWSWIRE) -- Ostarine, also known as MK-2866, is a SARM that is considered to be on the milder end of the spectrum and is often used by novices. Many people take this to mean that you do not need to complete the PCT …

Milliways, la révolution du chewing-gum, débarque en France

Milliways, la révolution du chewing-gum, débarque en France

Milliways, la marque britannique de chewing-gum sans plastique en pleine expansion, annonce son lancement en France avec l’ambition de transformer un marché resté figé depuis des décennies. Déjà leader de la catégorie “plastic-free” au Royaume-Uni, …

How To Get Rid of Herpes: Top OTC Supplements To Get Rid of Herpes From Herpesyl

How To Get Rid of Herpes: Top OTC Supplements To Get Rid of Herpes From Herpesyl

New York City, April 17, 2025 (GLOBE NEWSWIRE) -- Herpes is an infection caused by two different viruses - HSV-1 and HSV-2. It is a highly contagious virus that affects a person's physical, emotional, and psychological health. In this article, we explore …

Signing Day Sports/U.S. Army Bowl Combines Provide Recruitment Opportunities, Draw Strong Participation

Signing Day Sports/U.S. Army Bowl Combines Provide Recruitment Opportunities, Draw Strong Participation

SCOTTSDALE, AZ, April 17, 2025 (GLOBE NEWSWIRE) -- Signing Day Sports, Inc. (“Signing Day Sports” or the “Company”) (NYSE American: SGN), the developer of the Signing Day Sports app and platform, today provided an in-season update on the 2025 Military …

Ashland sets date for second-quarter fiscal 2025 earnings release and conference call webcast

Ashland sets date for second-quarter fiscal 2025 earnings release and conference call webcast

WILMINGTON, Del., April 17, 2025 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) today announced plans to issue its second-quarter fiscal 2025 earnings release at approximately 5 p.m. ET on Wednesday, April 30, 2025. The company’s live webcast with securities …

Is Testosterone a Steroid? TestoPrime – Best Legal Testosterone Supplement For Men Over 40 and 50

Is Testosterone a Steroid? TestoPrime – Best Legal Testosterone Supplement For Men Over 40 and 50

Glasgow City, April 17, 2025 (GLOBE NEWSWIRE) -- The question is asked by those who wish to know if it is identical to the illicit drugs that bodybuilders and sportsmen often take or if it isn't, and here's the reason. The body naturally produces …

Interius BioTherapeutics to Present at Upcoming Scientific Meetings

Interius BioTherapeutics to Present at Upcoming Scientific Meetings

PHILADELPHIA, April 17, 2025 (GLOBE NEWSWIRE) -- Interius BioTherapeutics, a clinical-stage company engineering targeted, programmable vectors for the precision delivery of genetic medicines, today announced that it will present at several upcoming …

Ligand Subsidiary Pelthos Therapeutics to Combine with Channel Therapeutics

Ligand Subsidiary Pelthos Therapeutics to Combine with Channel Therapeutics

Proposed transaction will raise $50 million in equity capital and enhance a publicly traded biopharmaceutical company focused on launching Pelthos’ ZELSUVMI™ ZELSUVMI is an FDA-designated novel drug and the first and only prescription medication approved …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service